Angiogenic gene therapy in patients with nonrevascularizable ischemic heart disease: a phase 2 randomized, controlled trial of AdVEGF121 (AdVEGF121) versus maximum medical treatment
2017 ◽
Vol 70
(16)
◽
pp. C162
2014 ◽
Vol 176
(2)
◽
pp. 367-374
◽
2000 ◽
Vol 15
(10)
◽
pp. 685-693
◽
2005 ◽
Vol 20
(s6)
◽
pp. S20-S24
◽